Leifeng.com news, on July 19, the official website of the China Securities Regulatory Commission issued an approval document, approving the registration application for the initial public offering of shares on the Shanghai United Imaging Medical Science and Technology Innovation Board.
The information comes from the official website of the China Securities Regulatory Commission
Previously, United Imaging Medical’s application for listing on the Science and Technology Innovation Board was accepted on December 31, 2021. CITIC Securities and CICC were its sponsors and planned to raise 12.48 billion yuan.
According to the prospectus, of the 12.48 billion funds raised, 6.168 billion will be used for next-generation product research and development projects, 3.126 billion will be used for high-end medical imaging equipment industrialization fund projects, 735 million will be used for marketing service network projects, and 452 million will be used for For informatization improvement projects, 2 billion yuan will be used to supplement working capital.
United Imaging’s medical products have entered nearly 900 tertiary hospitals across the country. The top 10 medical institutions in the country are all users of United Imaging, and 49 of the top 50 medical institutions have users.
United Imaging has a total of more than 2,600 authorized patents, including more than 1,200 domestic invention patents and more than 400 overseas invention patents. Invention patents account for nearly 70% of the total number of patents. United Imaging Medical has nearly 2,000 R&D personnel, accounting for more than 35% of the company’s total employees.
Among the leading high-end medical imaging companies in China, United Imaging Medical has good strength.
According to its prospectus, in 2020, United Imaging Medical will be the largest MR equipment manufacturer in the Chinese market in terms of new sales units. In China’s MR equipment market of 3.0T and above, the main market players are GE Healthcare, Siemens Healthcare, Philips Healthcare, Canon, and the only domestic company, United Imaging Healthcare, ranking fourth in terms of market share;
In addition, in China’s 1.5T MR equipment market and China’s superconducting MR equipment market, United Imaging Medical ranks first in terms of market share.
The information comes from the prospectus of United Imaging Medical
According to the prospectus, United Imaging Medical’s revenue in 2019, 2020, and 2021 was 2.98 billion yuan, 5.761 billion yuan, and 7.254 billion yuan, respectively; the net profit was -48.05 million yuan, 937 million yuan, and 1.4 billion yuan, respectively.
In 2018 and 2019, United Imaging Medical has not yet achieved profitability.
Mingfeng Medical, which is also engaged in high-end medical imaging equipment and was accepted for listing on the Science and Technology Innovation Board three weeks ago, has not achieved profitability during the 2019, 2020, and 2021 annual reporting periods, with an annual net loss of more than 200 million yuan.
According to the CIC research report, the market size of my country’s medical imaging equipment has exceeded 50 billion yuan in 2020. From 2015 to 2020, the compound growth rate of the market is 12.4%.
A reality is that several major foreign brands such as GPS still firmly occupy the market share of most medical devices. Domestic enterprises have been catching up with the brand advantages, channel advantages and technical advantages accumulated by imported brands for decades. It even surpasses the level of foreign countries. Leifeng.com
This article is reprinted from: https://www.leiphone.com/category/qixie/CrYQDamrgMVNSUde.html
This site is for inclusion only, and the copyright belongs to the original author.